What is the protocol for anti-rabies (Rabies) vaccination?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Anti-Rabies Vaccination Protocol

For previously unvaccinated individuals exposed to rabies, administer a 4-dose vaccine regimen on days 0,3,7, and 14, combined with rabies immune globulin (RIG) at 20 IU/kg body weight on day 0, along with immediate thorough wound cleansing. 1, 2

Immediate Wound Management

  • Wash all wounds thoroughly with soap and water for 15 minutes immediately after exposure 2, 3, 4
  • Apply a virucidal agent such as povidone-iodine solution to irrigate wounds if available 3, 5
  • This local wound treatment is perhaps the most effective single measure for preventing rabies and should be performed before any other intervention 2, 5

Post-Exposure Prophylaxis for Previously Unvaccinated Persons

Rabies Immune Globulin (RIG) Administration

  • Administer 20 IU/kg body weight on day 0 (the day the first vaccine dose is given) 1, 2, 3
  • If anatomically feasible, infiltrate the full dose around and into all wounds 1, 3
  • Any remaining volume should be administered intramuscularly at a site distant from vaccine administration 1, 3
  • RIG can be given up to and including day 7 of the vaccine series if not administered initially 1, 2, 3
  • Never administer RIG in the same syringe or anatomical site as the vaccine 1, 3
  • Do not exceed the recommended dose as this may suppress active antibody production 2, 3

Vaccine Schedule

  • Administer 4 doses of 1.0 mL each on days 0,3,7, and 14 1, 2
  • Use human diploid cell vaccine (HDCV) or purified chick embryo cell vaccine (PCECV) 1, 2
  • Day 0 is defined as the day the first dose is administered, not necessarily the day of exposure 2

Injection Sites

  • Adults and older children: deltoid muscle only 2, 3, 5
  • Young children: anterolateral thigh 2, 3, 5
  • Never use the gluteal area as this produces inadequate antibody response 2, 3, 5

Post-Exposure Prophylaxis for Previously Vaccinated Persons

Previously vaccinated individuals require only 2 vaccine doses (days 0 and 3) and do NOT need RIG. 1

  • This applies to persons who previously received complete pre- or post-exposure prophylaxis with cell-culture vaccines 1
  • RIG should not be administered to previously vaccinated persons as it may inhibit the anamnestic response 1
  • Wound cleansing remains essential 1

Special Population: Immunocompromised Patients

Immunosuppressed individuals require a 5-dose vaccine regimen (days 0,3,7,14, and 28) plus RIG. 1

  • This includes patients on corticosteroids, other immunosuppressive agents, or those with immunosuppressive illnesses 1
  • Immunosuppressive agents should not be administered during PEP unless essential for other conditions 1
  • Serologic testing should be performed 1-2 weeks after the final dose to confirm adequate antibody response 1, 2
  • Adequate response is defined as complete virus neutralization at a 1:5 serum dilution by RFFIT 1

Pre-Exposure Prophylaxis

For individuals at risk before exposure, administer 3 doses of vaccine on days 0,7, and 21 or 28. 1, 5

  • Recommended for rabies researchers, laboratory workers, veterinarians, animal handlers, cavers, and travelers to rabies-endemic areas 5
  • Same injection sites as post-exposure: deltoid for adults/older children, anterolateral thigh for young children 5
  • No RIG is administered for pre-exposure prophylaxis 5

Timing and Compliance Considerations

  • Initiate PEP as soon as possible after exposure, ideally within 24 hours 2
  • However, there is no absolute cutoff beyond which PEP should be withheld—treatment should begin immediately upon recognition of exposure, even if weeks or months have elapsed 2
  • Delays of a few days for individual vaccine doses are unimportant 2, 6
  • For substantial schedule deviations, assess immune status by serologic testing 7-14 days after the final dose 2, 6
  • Most interruptions do not require restarting the entire series—simply administer the missed dose and resume the schedule 6

Critical Pitfalls to Avoid

  • Never administer vaccine in the gluteal area (inadequate immune response) 2, 3, 5
  • Never give RIG and vaccine in the same syringe or anatomical site 1, 3
  • Never exceed the recommended RIG dose (may suppress antibody production) 2, 3
  • Never administer RIG to previously vaccinated persons (inhibits anamnestic response) 1
  • Never delay treatment waiting for animal testing results—begin immediately and discontinue only if testing proves the animal was not rabid 3, 5

Serologic Testing

  • Routine testing after PEP is not necessary for healthy immunocompetent individuals 1
  • Testing is indicated for immunosuppressed patients to confirm adequate response 1, 2
  • When performed, testing should occur 1-2 weeks after the final vaccine dose 1
  • Adequate titer is ≥0.5 IU/mL or complete neutralization at 1:5 dilution by RFFIT 1, 5

Human rabies is nearly 100% fatal once clinical symptoms develop, making proper PEP administration critical. 2, 7 When administered promptly and correctly, this protocol is highly effective in preventing rabies. 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Current Rabies Post-Exposure Prophylaxis Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Protocol for Administering Catch-Up Doses of Human Rabies Vaccine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Human Rabies: a 2016 Update.

Current infectious disease reports, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.